Table 1.
Malignancy | RARγ Expression | Impact on Disease |
---|---|---|
Acute myeloid leukemia | RARγ chimeric protein | Not responsive to retinoid-based therapy |
Colorectal carcinoma | Overexpression | Resistance to chemotherapeutics |
Cholangiocarcinoma | Overexpression | Poor prognosis and drug resistance |
Hepatocellular carcinoma | Overexpression | Promotes growth of xenografts |
Renal cell carcinoma | Overexpression | May contribute to disease progression |